Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity
暂无分享,去创建一个
[1] R. Wilkinson,et al. IFN--and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-37 , 2007 .
[2] P. Dhawan,et al. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[3] J. Aloia,et al. Re: epidemic influenza and vitamin D. , 2007, Epidemiology and infection.
[4] J. Todd,et al. Association of the Vitamin D Metabolism Gene CYP27B1 With Type 1 Diabetes , 2007, Diabetes.
[5] Sara Gandini,et al. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.
[6] R. Modlin,et al. Cutting Edge: Vitamin D-Mediated Human Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on the Induction of Cathelicidin1 , 2007, The Journal of Immunology.
[7] P. Lipsky,et al. Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation , 2007, The Journal of Immunology.
[8] Robert J Wilkinson,et al. A single dose of vitamin D enhances immunity to mycobacteria. , 2007, American journal of respiratory and critical care medicine.
[9] C. Mathieu,et al. Mechanism and potential of the growth-inhibitory actions of vitamin D and ana-logs. , 2007, Current medicinal chemistry.
[10] J. Söderlund,et al. The antimicrobial peptide LL-37 inhibits HIV-1 replication. , 2007, Current HIV research.
[11] Robert J Wilkinson,et al. IFN-γ- and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-371 , 2007, The Journal of Immunology.
[12] D. Eyles,et al. Vitamin D deficiency during various stages of pregnancy in the rat; its impact on development and behaviour in adult offspring , 2007, Psychoneuroendocrinology.
[13] P. Lips,et al. 13th Workshop consensus for vitamin D nutritional guidelines , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[14] Junliang Pan,et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 , 2007, Nature Immunology.
[15] A. Sher,et al. Cooperation of Toll-like receptor signals in innate immune defence , 2007, Nature Reviews Immunology.
[16] Y. Helfrich,et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. , 2007, The Journal of clinical investigation.
[17] A. Ascherio,et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.
[18] C. Doglioni,et al. Treatment of Experimental Autoimmune Prostatitis in Nonobese Diabetic Mice by the Vitamin D Receptor Agonist Elocalcitol1 , 2006, The Journal of Immunology.
[19] S. Romagnani. Regulation of the T cell response , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[20] K. Badenhoop,et al. Protection From Type 1 Diabetes by Vitamin D Receptor Haplotypes , 2006, Annals of the New York Academy of Sciences.
[21] S. Madronich,et al. Epidemic influenza and vitamin D , 2006, Epidemiology and Infection.
[22] A. Zittermann. Vitamin D and disease prevention with special reference to cardiovascular disease. , 2006, Progress in biophysics and molecular biology.
[23] R. Gallo,et al. Control of the innate epithelial antimicrobial response is cell‐type specific and dependent on relevant microenvironmental stimuli , 2006, Immunology.
[24] P. Hershberger,et al. The antitumor efficacy of calcitriol: preclinical studies. , 2006, Anticancer research.
[25] Yan Liu,et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. , 2006, Journal of the National Cancer Institute.
[26] Maureen L. Coleman,et al. Genomic Islands and the Ecology and Evolution of Prochlorococcus , 2006, Science.
[27] D. Tamandl,et al. Vitamin D3 down‐regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen‐associated molecular patterns , 2006, European journal of immunology.
[28] C. Rumende,et al. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. , 2006, Acta medica Indonesiana.
[29] A. Ponsonby,et al. UVR, Vitamin D and Three Autoimmune Diseases—Multiple Sclerosis, Type 1 Diabetes, Rheumatoid Arthritis , 2005, Photochemistry and photobiology.
[30] M. Campbell,et al. Biological actions of extra-renal 25-hydroxyvitamin D-1α-hydroxylase and implications for chemoprevention and treatment , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[31] H. Koeffler,et al. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] M. Horowitz,et al. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women , 2005, Clinical endocrinology.
[33] L. Nguyen,et al. Alternative Splicing of Vitamin D-24-Hydroxylase , 2005, Journal of Biological Chemistry.
[34] M. Guy,et al. Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue , 2005, Clinical Cancer Research.
[35] H. Törmä,et al. Vitamin D induces the antimicrobial protein hCAP18 in human skin. , 2005, The Journal of investigative dermatology.
[36] P. Lips,et al. Estimates of optimal vitamin D status , 2005, Osteoporosis International.
[37] S. Harris. Vitamin D in type 1 diabetes prevention. , 2005, The Journal of nutrition.
[38] J. McGrath,et al. Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain , 2005, Journal of Chemical Neuroanatomy.
[39] N. Kagawa,et al. Metabolism of vitamin D3 by cytochromes P450. , 2005, Frontiers in bioscience : a journal and virtual library.
[40] H. DeLuca. Overview of general physiologic features and functions of vitamin D. , 2004, The American journal of clinical nutrition.
[41] John H. White,et al. Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression , 2004, The Journal of Immunology.
[42] S. Hankinson,et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[43] F. Wrba,et al. 25-Hydroxyvitamin D3-1α-hydroxylase Expression in Normal and Malignant Human Colon , 2004, Journal of Histochemistry and Cytochemistry.
[44] M. Willingham,et al. Pancreatic cancer cells express 25-hydroxyvitamin D-1α-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3 , 2004 .
[45] M. Hewison,et al. Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[46] C. Mathieu,et al. Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice , 2004, Diabetologia.
[47] M. Hakama,et al. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) , 2000, Cancer Causes & Control.
[48] J. Cerhan,et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. , 2004, Arthritis and rheumatism.
[49] Aristides G. Eliopoulos,et al. Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells1 , 2003, The Journal of Immunology.
[50] G. Tenderich,et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? , 2003, Journal of the American College of Cardiology.
[51] A. Ponsonby,et al. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. , 2002, Toxicology.
[52] M. Holick,et al. 25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[53] M. Uskoković,et al. A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .
[54] C. Mathieu,et al. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. , 2002, Trends in Molecular Medicine.
[55] D. Chant,et al. Long-term trends in sunshine duration and its association with schizophrenia birth rates and age at first registration — data from Australia and the Netherlands , 2002, Schizophrenia Research.
[56] W. Grant. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet‐B radiation , 2002, Cancer.
[57] David F. Richards,et al. In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.
[58] M. Uskoković,et al. A 1 , 25-Dihydroxyvitamin D 3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .
[59] H. DeLuca,et al. Vitamin D: its role and uses in immunology 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] Elina Hyppönen,et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.
[61] Huub F. J. Savelkoul,et al. 1α,25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4+ T Cells to Enhance the Development of Th2 Cells1 , 2001, The Journal of Immunology.
[62] L. Adorini,et al. Regulatory T Cells Induced by 1α,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance1 , 2001, The Journal of Immunology.
[63] B. Christensson,et al. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator , 2001, Nature Medicine.
[64] L. Adorini,et al. Regulatory T Cells Induced by 1 ,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance , 2001 .
[65] C. Mathieu,et al. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). , 2000, Diabetes.
[66] P. Allavena,et al. Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells1 , 2000, The Journal of Immunology.
[67] L. Adorini,et al. 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.
[68] B. Hollis,et al. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. , 1999, The journal of nutrition, health & aging.
[69] H. DeLuca,et al. Current understanding of the molecular actions of vitamin D. , 1998, Physiological reviews.
[70] T. Chen,et al. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[71] P. Galan,et al. Prevalence of Vitamin D Insufficiency in an Adult Normal Population , 1997, Osteoporosis International.
[72] Kenneth M. Murphy,et al. Functional diversity of helper T lymphocytes , 1996, Nature.
[73] H. Spiegelberg,et al. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. , 1995, The Journal of nutrition.
[74] R. Bouillon,et al. Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.
[75] D. Bikle,et al. Vitamin D, calcium, and epidermal differentiation. , 1993, Endocrine reviews.
[76] E. Ritz,et al. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. , 1993, Blood.
[77] H. Koeffler,et al. 25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. , 1987, The Journal of clinical endocrinology and metabolism.
[78] S. Manolagas,et al. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. , 1986, Journal of immunology.
[79] G. Rook,et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. , 1986, Immunology.
[80] J. Adams,et al. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. , 1985, Journal of immunology.
[81] M. Fanger,et al. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). , 1984, The Journal of clinical investigation.
[82] J. Adams,et al. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. , 1984, The Journal of clinical investigation.
[83] S. Krane,et al. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. , 1983, The Journal of clinical endocrinology and metabolism.
[84] J. Adams,et al. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. , 1983, The Journal of clinical investigation.
[85] S. Manolagas,et al. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. , 1983, Science.
[86] A. Norman,et al. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. , 1981, The New England journal of medicine.
[87] M. Haussler,et al. Biochemical evidence for 1,25-dihydroxyvitamin D receptor macromolecules in parathyroid, pancreatic, pituitary, and placental tissues. , 1980, Life sciences.
[88] T. Oppé,et al. Vitamin D deficiency. , 1979, British medical journal.
[89] W. C. Spackman. Correspondence , 1921, The Indian medical gazette.